These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6643333)

  • 1. Latamoxef (moxalactam) kinetics in volunteers studied by a specific HPLC assay technique.
    Shepherd AM; Hardin TC; Ludden TM; Miner DJ; Coleman DL
    J Antimicrob Chemother; 1983 Oct; 12(4):377-86. PubMed ID: 6643333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of ceftazidime and moxalactam.
    Tjandramaga TB; Van Hecken A; Mullie A; Verbesselt R; De Schepper PJ; Verbist L
    Antimicrob Agents Chemother; 1982 Aug; 22(2):237-41. PubMed ID: 6765416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vincon G; Wone C
    Eur J Clin Pharmacol; 1986; 30(3):299-302. PubMed ID: 3732364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of moxalactam in elderly subjects.
    Andritz MH; Smith RP; Baltch AL; Griffin PE; Conroy JV; Sutphen N; Hammer MC
    Antimicrob Agents Chemother; 1984 Jan; 25(1):33-6. PubMed ID: 6703682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration-time courses of pefloxacin in plasma and milk of lactating she-camels (Camelus dromedarius).
    Goudah A; Shah SS; Shin HC; Chang BJ; Shim JH; Abd El-Aty AM
    Berl Munch Tierarztl Wochenschr; 2008; 121(11-12):432-9. PubMed ID: 19086693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of moxalactam in patients with malignant disease.
    Estey EH; Weaver SS; Ho DH; Bodey GP
    Antimicrob Agents Chemother; 1981 Apr; 19(4):639-44. PubMed ID: 6454389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of single intravenous and intramuscular doses of cefotetan in normal human volunteers.
    Guibert J; Kitzis MD; Yvelin C; Acar JF
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():201-6. PubMed ID: 6573317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of single-dose administration of moxalactam in unweaned calves.
    Soback S
    Am J Vet Res; 1989 Apr; 50(4):498-501. PubMed ID: 2653122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of FCE 22101 in man following different modes of administration.
    Lovering AM; White LO; Lewis DA; MacGowan AP; Routh KR; Pickin DM; Reeves DS
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():179-95. PubMed ID: 2732141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects.
    Israel KS; Black HR; Brier GL; Wolny JD; DeSante KA
    Antimicrob Agents Chemother; 1982 Jul; 22(1):94-102. PubMed ID: 6214998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic and clinical studies of latamoxef (moxalactam) in neonates and premature infants].
    Fujii R; Hashira S; Takimoto M; Oka T; Yoshioka H; Tsuchida A; Sanae N; Maruyama S; Tojo M; Sunakawa K
    Jpn J Antibiot; 1984 Jun; 37(6):973-90. PubMed ID: 6492388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state moxalactam pharmacokinetics in patients: noncompartmental versus two-compartmental analysis.
    Swanson DJ; Reitberg DP; Smith IL; Wels PB; Schentag JJ
    J Pharmacokinet Biopharm; 1983 Aug; 11(4):337-53. PubMed ID: 6668547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic analysis of cefquinome in healthy chickens.
    Xie W; Zhang X; Wang T; Du S
    Br Poult Sci; 2013; 54(1):81-6. PubMed ID: 23444857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis.
    Contrepois A; Vallois JM; Garaud JJ; Pangon B; Mohler J; Meulemans A; Carbon C
    J Antimicrob Chemother; 1986 Feb; 17(2):227-37. PubMed ID: 3516963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of thiamphenicol in dogs.
    Castells G; Intorre L; Franquelo C; Cristòfol C; Pérez B; Martí G; Arboix M
    Am J Vet Res; 1998 Nov; 59(11):1473-5. PubMed ID: 9829409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and selected behavioral responses to butorphanol and its metabolites in goats following intravenous and intramuscular administration.
    Carroll GL; Boothe DM; Hartsfield SM; Waller MK; Geller SC
    Vet Anaesth Analg; 2001 Oct; 28(4):188-195. PubMed ID: 28404243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of cefodizime in children.
    Boccazzi A; Fusi G; Mezzopane AM; Maretti M; Careddu P
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():83-7. PubMed ID: 2074256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the pharmacokinetics of latamoxef in normal and impaired renal function.
    Höffler D; Koeppe P; Moecke D
    Arzneimittelforschung; 1984; 34(3):317-20. PubMed ID: 6539614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pharmacokinetic method for analysis of placental transfer of latamoxef in humans.
    Yamamoto T; Yasuda J; Kanao M; Okada H; Oguma T; Yamada H
    Clin Pharmacokinet; 1986; 11(2):154-63. PubMed ID: 3956048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of danofloxacin after single dose intravenous, intramuscular and subcutaneous administration to loggerhead turtles Caretta caretta.
    Marín P; Bayón A; Fernández-Varón E; Escudero E; Clavel C; Almela R; Cárceles CM
    Dis Aquat Organ; 2008 Dec; 82(3):231-6. PubMed ID: 19244975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.